Zymeworks (ZYME) Stock Research

Today

Zymeworks price target raised by $4 at B. Riley, here's why

ZYME

8:19 AM

Citi adds 'upside 90-day catalyst watch' on Zymeworks in FDA decision

ZYME

5:27 AM

Friday

Zymeworks price target raised by $1 at Truist, here's why

ZYME

Aug 7, 10:22 AM

Zymeworks price target lowered by $1 at Stifel

ZYME

Aug 7, 9:13 AM

Zymeworks price target raised by $3 at Wells Fargo, here's why

ZYME

Aug 7, 7:24 AM

Thursday

Zymeworks reports Q2 EPS (62c), consensus (55c)

ZYME

Aug 6, 5:36 PM

Wednesday

Zymeworks price target raised to $51 from $46 at H.C. Wainwright

Aug 5, 12:55 PM

Over a week ago

Zymeworks management to meet with B. Riley

ZYME

Jul 21, 2:51 PM

Zymeworks price target raised by $3 at Truist, here's why

ZYME

Jul 7, 9:15 AM

Zymeworks price target raised by $3 at Wells Fargo, here's why

ZYME

Jun 30, 6:24 AM

Zymeworks price target raised to $37 from $35 at Citi

Jun 30, 5:41 AM

Morning Movers: Comcast surges after announcing spinoff of NBCUniversal

Jun 29, 9:04 AM

Theravance Biopharma to be acquired by Zymeworks for $17.00 per share in cash

Jun 29, 6:12 AM

Zymeworks to acquire Theravance Biopharma for $17.00 per share, or $929M

Jun 29, 6:06 AM

Zymeworks to acquire Theravance Biopharma for $17.00 per share

Jun 29, 6:00 AM

Context Therapeutics selloff brings buying opportunity, says JonesResearch

Jun 15, 1:30 PM

Zymeworks presents new clinical data on Phase 1 study of ZW191

ZYME

Jun 14, 7:13 PM

Zymeworks assumed with a Buy at Truist

ZYME

Jun 9, 8:07 AM

Citizens biotech analysts hold a dinnermeeting at ASCO

May 22, 3:19 PM

Zymeworks authorizes share repurchase program of up to $125M

ZYME

May 14, 4:52 PM

Zymeworks reports Q1 EPS (59c), consensus (10c)

ZYME

May 7, 4:23 PM

Zymeworks reports results from dose-escalation part of Phase 1 study for ZW191

ZYME

Apr 21, 5:33 PM

Today

Zymeworks price target raised by $4 at B. Riley, here's why

ZYME

8:19 AM

Citi adds 'upside 90-day catalyst watch' on Zymeworks in FDA decision

ZYME

5:27 AM

Friday

Zymeworks price target raised by $1 at Truist, here's why

ZYME

Aug 7, 10:22 AM

Zymeworks price target lowered by $1 at Stifel

ZYME

Aug 7, 9:13 AM

Zymeworks price target raised by $3 at Wells Fargo, here's why

ZYME

Aug 7, 7:24 AM

Thursday

Zymeworks reports Q2 EPS (62c), consensus (55c)

ZYME

Aug 6, 5:36 PM

Wednesday

Zymeworks price target raised to $51 from $46 at H.C. Wainwright

Aug 5, 12:55 PM

Over a week ago

Zymeworks management to meet with B. Riley

ZYME

Jul 21, 2:51 PM

Zymeworks price target raised by $3 at Truist, here's why

ZYME

Jul 7, 9:15 AM

Zymeworks price target raised by $3 at Wells Fargo, here's why

ZYME

Jun 30, 6:24 AM

Zymeworks price target raised to $37 from $35 at Citi

Jun 30, 5:41 AM

Morning Movers: Comcast surges after announcing spinoff of NBCUniversal

Jun 29, 9:04 AM

Theravance Biopharma to be acquired by Zymeworks for $17.00 per share in cash

Jun 29, 6:12 AM

Zymeworks to acquire Theravance Biopharma for $17.00 per share, or $929M

Jun 29, 6:06 AM

Zymeworks to acquire Theravance Biopharma for $17.00 per share

Jun 29, 6:00 AM

Context Therapeutics selloff brings buying opportunity, says JonesResearch

Jun 15, 1:30 PM

Zymeworks presents new clinical data on Phase 1 study of ZW191

ZYME

Jun 14, 7:13 PM

Zymeworks assumed with a Buy at Truist

ZYME

Jun 9, 8:07 AM

Citizens biotech analysts hold a dinnermeeting at ASCO

May 22, 3:19 PM

Zymeworks authorizes share repurchase program of up to $125M

ZYME

May 14, 4:52 PM

Zymeworks reports Q1 EPS (59c), consensus (10c)

ZYME

May 7, 4:23 PM

Zymeworks reports results from dose-escalation part of Phase 1 study for ZW191

ZYME

Apr 21, 5:33 PM

Company News

Charts